stamas5, I am going to assume you are a type 2 with that a1c (6.6) and none of the symptoms of a type 1 that is in a honeymoon phase. You appear to be both insulin naïve, and you have never taken any oral drugs for diabetes. If you read or watch some Al Mann videos, he would call you an ideal candidate for Afrezza at meal times. If you are a type 2, you are one of the people Sanofi will be marketing Afrezza to in their promotions.
kevinmik, I found it. It is from WDBJ in Virginia about Dr. Bailey. Good to see.
kevinmik, where can I find the endo video you reference? What should I google to find it. Thanks.
promannkind, I just checked, and Spiro went below 120 in just two days on Afrezza. 19 days later he got into the 80s. You can get samples and a first prescription free flyer plus next prescription $30. Rather than take any orals, I would pay for Afrezza myself if/until the insurance comes through. Since you are plagued by the after meal spikes, it should be easy with Afrezza to show your doc fast improvement in range and the start of a much lower A1c. Then if special things are needed for insurance, the doc can be more motivated to help.
promannkind, sounds like you are a type 2. You really need to read up on side effects of metformin as well as Januvia. I would never take either of those drugs, and I mean I would refuse. Either and both can cause plenty of trouble for you. I have no idea what your A1c is now, but if it is not way high, you likely would just need Afrezza at meal times and check how you do after a month or two on your blood glucose levels. If your A1c is way high and you are type 2, you will likely need subcutaneous insulin anyway in addition to Afrezza.
bigkid531, About an hour ago I did exactly what you suggested, i.e., I read the SeekingAlpha (SA) transcript of the SNY earnings call. It appears the transcript could not provide an answer to my question either, because it simply states "unknown" for the word I am trying to discover relative to Germany. Perhaps you have not read the transcript you cited.
In addition I have found Tremendous transcription errors in SA transcript documents when I have from time to time compared certain segments of an audio call (that mattered to me) to the text of any particular transcript. The quality of the SA transcripts is less than customer delightful, but it is essentially free. There is that. I should also say from time to time I have found text in SA transcripts that is correct when compared to my misunderstanding of words in an audio call. Free is good.
mnholdem, so it would appear to make a reasonable comparison you would need to find the Insulin Analogs, Short-Acting group numbers. Then it might be more of an apples to apples comparison of the numbers.
kimi_held, I listened to the Sanofi earnings call replay, and toward the end of the call they talked about an ADNOC procedure some drug (I think it was Toujeo) did not have to go through in Germany. I cannot be sure how to spell adnoc, because it was hard for me to understand the term through their French accents. Do you recognize this term that drugs sometimes go through in Germany? Is it similar to an advisory committee with the FDA in the USA?
sellhighdrinklow, If I had a cardiologist who prescribed Crestor, refused to prescribe Lipitor, but I wanted Lipitor, I would go to another cardiologist who would give me a Lipitor prescription. What is the issue with diabetics not mostly doing the same thing if their endo/gp will not prescribe(not just sampes) Afrezza when patients say they want it?
Why did you get just Afrezza samples and not a prescription for Afrezza? While you are feeling better, it appears your Dexcom is indicating you must be in some blood glucose range you have not experienced before.
I read your posts about the hassle (what I call hassle anyway) you had to go through just to get the doc to agree to give you samples.
amstelytle, I noticed that too, because the Sanofi table and text stated explicitly the Toujeo, "Sales of the product were #$%$7 million in the first quarter which primarily reflected wholesaler demand in advance of the launch." However the Afrezza statement was, "Sales of the product were #$%$1 million in the first quarter."
It seemed to me there was a difference the earnings press release was noting for the reader. The quoted text above is directly from the Sanofi earnings press release.
amstelytle, the first 90 day doctor-measured A1c's will start in May, and then four and five month duration A1c's can follow after that when all the other prandial insulins are for certain out of the system. The real, much reduced, doctor-measured A1c's will get plenty of doctors' attention coming from so many differing types of diabetics with so many differing eating habits, etc.
factspls88, I read Brian Feroldi's article you referenced. He recognizes in the article MNKD has a good drug pipeline possible with the Technosphere delivery system. He lives in either Rhode Island or the Boston area, and perhaps he went to the Andrea Leone-Bay presentation on inhaled oxyntomodulin yesterday. He just recently was a territory manager for Insulet, and that means he knows plenty about insulin and diabetes. He just started writing articles this month after a good number of years with Insulet.
Has anyone seen an analyst's report on Leone-Bay's presentation today in Boston on inhaled oxyntomodulin. It is positioned as a possible treatment for obesity. Perhaps someone reading this may have been at the event today.
joeblow180, OK I found you answered a few hours ago you took two 4U doses of Afrezza back to back. Thanks for the information.
doctorgreenback, just a point of order. I believe you meant to write, "they are NOT worried about 4-12u." Am I wrong?
doctorgreenback, why is there talk about a 30U dose. Isn't that an extreme outlier type 2. If yes, why is that an important concern?
dtrouble1003, isn't your girlfriend(gf) one who has been to her doctor, and he would not prescribe it to her? I think I remember this some months ago. Is she going to watch and love it from social media without getting in the fight to use Afrezza?